logo
High Yields And Higher Returns: Inside The U.K. Cannabis Industry

High Yields And Higher Returns: Inside The U.K. Cannabis Industry

Forbes21-03-2025

The U.K. cannabis sector is projected to be worth nearly $570 million by 2028.
Guarded by razor wire, over 1,300 alarms, and a 24/7 ex-military security presence, Dalgety's medical cannabis manufacturing facility is intentionally hard to find (I've got the Uber receipts to prove it).
The 30,000-ft U.K. site saw £10m in investment and over four years of regulatory checks before shipping its first products to patients earlier this year.
Head grower Brady Green has over 15 years of experience cultivating medical cannabis. He relocated from Canada in 2023, where he was at the forefront of the industry, leading a team of 450 growers at a 13-acre facility.
'I handed him [Green] a blank piece of paper and asked him to draw the perfect cannabis facility,' Dalgety's CEO, James Leavesley, tells me when I eventually arrive.
Today that sketch is a reality.
The site has been specifically designed to grow cannabis under highly controlled conditions, using energy-efficient lighting, cutting-edge hydroponic systems, and strict climate control to replicate the changing seasons throughout the plant's life cycle.
The temperature —and the smell— get more intense as we progress through each stage of the growth cycle. In the cultivation rooms, the temperature is controlled to the nearest 0.5 ̊C and humidity to the nearest 1%, with selective use of air pressure so precise that you can see the spike in CO2 on the monitors when we exit the room.
The first company to obtain an EU-GMP license for the cultivation, manufacture and supply of a medical cannabis flower API from the U.K.'s Medicines and Healthcare Regulatory Authority (MHRA), Dalgety is currently producing enough to fulfil 4,000 prescriptions per month.
By 2026, when it expands to full capacity, it aims to produce 2,600 kg of cannabis per year, with yields boldly estimated to be 82% higher than the top 1% of cultivators worldwide.
'We're looking to increase our output by five and a half times by 2026,' Leavesley says. "We're setting our sights on the future and are optimistic that the market will grow quickly.'
Dalgety is the first company to obtain an EU-GMP license for the cultivation, manufacture and supply ... More of a medical cannabis flower API from the MHRA. CEO James Leavesley. Dalgety stock photography 2023. Picture by Shaun Fellows / Shine Pix Ltd
The U.K. is already known as the world's biggest producer and exporter of legal cannabis for medical and scientific purposes, largely due to Jazz Pharmaceuticals (formerly GW Pharma), which has manufactured the FDA-approved cannabis-based medicines, Epidiolex and Sativex, since the 90s.
Since medical cannabis was legalized in 2018, several others have seen the opportunity— and growing demand— for a domestic market. Target Healthcare now manufactures Bedrocan oils in Glasgow and the North East-based Rokshaw Laboratories was taken over by Curaleaf — the world's largest cannabis company— in 2019.
Along with Germany, the U.K. has been identified as a key market in the European cannabis sector, with industry analysts at Prohibition Partners, forecasting that the market will grow from $255 million in 2024 to nearly $570 million by 2028. [In the interests of full transparency, Prohibition Partners also own a media brand I write for in the U.K.]
The lack of NHS access—fewer than five patients have been able to obtain a prescription through the country's national healthcare service—has paved the way for a prospering private market, with over 40 clinics now prescribing cannabis.
Exact patient numbers are hard to come by — some estimates suggest there could be as many as 60,000 — while the NHS Business Services Authority, which collects data on private prescriptions, shows over 300,000 items were prescribed between April 2023-24, more than double that of the previous 12 months.
In its recent U.K. report, Cannamonitor estimates that 79% of these prescriptions are for flower, with many high in THC and almost all imported from overseas.
Dalgety is getting ready to meet this demand. Five new strains have been selected for market launch in 2025, with over 100 varieties in its library.
The team drew on Green's experience when choosing genetics, importing 600 cannabis cuttings from the west coast of Canada (remarkably, only one didn't survive the journey).
'We worked with partners to import tissue culture cuttings so we didn't have to start with seed trials and spend a year finding genetics,' Green explains.
'Now we're diversifying. Our next step is to introduce strains that we think people will like, but don't necessarily know to exist, because it's difficult to grow so you don't find it on the illegal markets— exotic flavor profiles. We have such a small window of what we think is possible. Cannabis has the genetic potential to express every terpene on earth."
Head grower Brady Green has 15 years of experience in the Canadian market. Dalgety stock photography ... More 2023. Picture by Shaun Fellows / Shine Pix Ltd
All this is going on while a Labour government refuses to budge from its hard stance on cannabis.
Although the Mayor of London, Sadiq Khan, proposed decriminalization back in 2022, Prime Minister Keir Starmer has made it clear he has 'no intention' of changing drug laws or treating cannabis use as a 'low-level' crime.
Even calls to widen the availability of prescriptions for children with treatment-resistant epilepsy (many of whom are still unable to access the treatment at all) were shut down by Health Minister Karen Smith in the House of Commons in January— despite her previous support while in opposition.
But many feel policy change is inevitable, especially given European countries including Malta, Luxembourg, Czechia, Switzerland, the Netherlands and Germany are all moving towards regulation.
A recent report by Transform Drug Policy Foundation outlines how regulating cannabis for adult non-medical use in the U.K. could generate up to £1.5 billion in annual net benefits to the Treasury. The High Returns: The Economic Benefits of UK Cannabis Legalisation, report, predicts that a mature regulated market could capture up to 80% of the current illegal cannabis market within five years while creating up to 15,500 full-time jobs across cultivation, manufacturing, retail and ancillary services.
Dalgety received over 2,500 applications in 48 hours in response to an advert for a 'cannabis grower" on the job search site, Indeed. The company now takes a more considered approach to hiring, with all employees required to undergo extensive background checks by the Home Office.
The point still stands. With cannabis thought to be the biggest source of daily cash flow for operators in organized crime, polling suggests that in the U.K. and the U.S., the economic argument for regulation receives the most public support. Analysts at Transform believe this argument, while secondary to public health and social justice reasons, is becoming increasingly important politically, too.
'The economic dimensions of the cannabis reform debate are undoubtedly gaining political salience, particularly as governments face growing budgetary pressures,' write co-authors Ester Kincová and Steve Rolles.
'Public support for cannabis reform, particularly for economic reasons such as disrupting illegal profits and the potential tax windfall, is growing in both the U.S. and the U.K. Legal cannabis markets are expanding globally with reforms now unfolding on every continent. This global momentum, coupled with growing public support in the UK – polls show a majority favors legislation – suggests reform is increasingly likely, if not inevitable, with economic arguments potentially decisive.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

20 million eggs recalled from Walmart, Safeway other stores in WA, other states
20 million eggs recalled from Walmart, Safeway other stores in WA, other states

Yahoo

time36 minutes ago

  • Yahoo

20 million eggs recalled from Walmart, Safeway other stores in WA, other states

A salmonella outbreak has caused the recall of 1.7 million dozen eggs and has sickened 79 people in seven states. Four people in Washington have been reported sick, and the U.S. Food and Drug Administration continues to track the outbreak. There have been no deaths. The recall was issued June 6 for 20 million eggs distributed to Walmart, Safeway, chains owned by Kroger and various other independent and chain supermarkets around the country. The Centers for Disease Control is recommending that people throw the eggs away. Hilmar, California's August Egg Co., a division of Gemperle Enterprises, produced the eggs and issued the recall last week. 'August Egg Company is not selling fresh shell eggs at this time,' the company-written, FDA-posted recall notice said. 'Our firm has voluntarily been diverting eggs to an egg-breaking plant for over 30 days, which pasteurizes the eggs and kills any potential foodborne pathogens.' Packaging for the recalled eggs will have plant code P-6562 or CA5330 with the Julian Dates between 32 to 126. The eggs that went to Walmart stores had sell-by dates from March 4 through June 19. Other retailers got eggs with 'sell by dates' from March 4 through June 4. The recall section of Walmart's website say the egg recall involves its stores in two dozen states, including Washington. The FDA's recall list includes California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana and Illinois. Here are specific brands to look for: ▪ Marketside (a Walmart store brand): Organic Large Cage Free Brown Eggs in cartons of 12 and 18; Large Cage Free Brown Eggs in cartons of 12 and 18. ▪ First Street (a Smart & Final house brand): Cage Free Large Brown loose eggs. ▪ Clover: Organic Large Brown Eggs, one dozen. ▪ Nulaid: One dozen Medium Brown Cage Free, one dozen Jumbo Brown Cage Free. ▪ O Organics: Cage Free Large Brown, six eggs; and Large Brown, 12 and 18 eggs. This brand will be found at Safeway and other Albertson's-owned stores. ▪ Raley's (store brand): Large Cage Free Brown, 12 eggs: Organic Large Cage Free Brown, 12 and 18 eggs. ▪ Simple Truth: Cage Free Large Brown and Medium Brown 18 eggs. This brand will be found at Food 4 Less, Ralphs and other Kroger-owned chains. ▪ Sun Harvest: Organic Large Cage Free Brown Eggs in cartons of 12 and 18. ▪ Sunnyside: Organic Large Cage Free Brown Eggs in cartons of 12 and 18; and Large Cage Free Brown Eggs in cartons of 12 and 18. An outbreak update from the Centers for Disease Control and Prevention says 79 people have been sickened in this outbreak with 21 hospitalizations. Most of those have been in California, with four in Washington. The remaining 10 break down as Nevada (four); Arizona (three); Nebraska and New Jersey (two each); and Kentucky (one). Salmonella outbreaks tend to be under-counted because most people recover without medical attention. The CDC estimates about 1.35 million people in the United States will get salmonella each year. Of that number, 26,400 will be hospitalized, usually driven to the hospital by bloody diarrhea, and 420 will die. Usually, salmonella means a few days of diarrhea, vomiting, fever and stomachaches. The Mayo Clinic notes that salmonella symptoms include: Nausea and/or vomiting Abdominal cramps Diarrhea and/or blood in the stool Fever Chills Headache If you have any of the recalled eggs listed above, return them to the store for a refund or throw them deep into the garbage. If you have any questions about the recalls, call August Farms at 800-710-2554, 9 a.m. to 5 p.m. daily, Pacific time.

Dr Pepper recall upgraded over serious health risk
Dr Pepper recall upgraded over serious health risk

Yahoo

time36 minutes ago

  • Yahoo

Dr Pepper recall upgraded over serious health risk

A recall on cases of Dr Pepper has been upgraded due to a serious health risk. On May 23, the United States Food and Drug Administration (FDA) and Dr Pepper issued a voluntary recall on 19,203 12-pack and 24-pack cases of 12-ounce cans of Dr Pepper Zero Sugar. Then, on Thursday, the FDA's recall was upgraded to Class II, which the organization describes as a 'situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.' Although the cans, produced by Jacksonville, Florida-based Pepsi Beverages Company, were labeled 'zero sugar,' they were found to contain the full amount of sugar that is in a regular can, which is around 39 grams. The recalled cans have the product code XXXXRS05165 with a 'best by' date of February 16, 2026. The soda was only distributed to retailers in Florida, Georgia, and South Carolina. The recall only applies to Dr Pepper Zero Sugar and not any other Dr Pepper products. Customers who have purchased the affected Dr Pepper cans are urged to return the product to where they were purchased in exchange for a full refund or to throw them away. A mislabel like this can lead to issues for anyone who needs to avoid sugar, or for diabetics who need to strictly monitor their sugar intake. If a person with diabetes eats too much sugar, it can lead to hyperglycemia, which is a condition where blood sugar levels become dangerously high, resulting in symptoms such as increased thirst and blurred vision. According to the Cleveland Clinic, if hyperglycemia is left untreated, it can develop into diabetes-related ketoacidosis (DKA), which can be fatal. The upgraded recall comes after Coca-Cola sent a letter to Costco members last week announcing that they were voluntarily recalling Topo Chico Mineral Water due to the possible presence of Pseudomonas aeruginosa, a bacteria that occurs naturally in water sources, including mineral water. According to the letter sent to customers, the health risks of consuming mineral water with Pseudomonas are 'very low' in healthy individuals and will only cause 'minor health consequences' in people with 'weakened immune systems.' 'The safety and quality of the products we offer our consumers is our top priority,' the letter read. The recall specifically applies to bottles that were sold at select Costco warehouses in Texas and Louisiana from May 20 to May 29, 2025. The water bottles were sold in 18-packs and have the lot number 13A2541 printed on both the case's packaging and the neck of the individual bottles. Customers who have purchased the affected water bottles are urged to return them to their local Costco in exchange for a full refund. Any questions regarding the recall can be directed to Coca-Cola using the phone number 1-800-GET-COKE.

Canada to hit NATO spending target this year as it shifts defense focus toward EU
Canada to hit NATO spending target this year as it shifts defense focus toward EU

Yahoo

time36 minutes ago

  • Yahoo

Canada to hit NATO spending target this year as it shifts defense focus toward EU

Canada will reach NATO's defense spending target of 2% of GDP this year, five years ahead of schedule, Prime Minister Mark Carney announced on June 9. Speaking at the University of Toronto, Carney said the move is part of a strategic pivot away from reliance on the U.S. and toward deeper cooperation with the European Union, citing growing security threats from Russia, China, and other adversaries. Carney said Canada's current military capabilities are inadequate, noting that only one of four submarines is operational and much of the maritime and land fleet is outdated. To reverse this trend, his government is launching a $6.8 (9.3 billion Canadian dollars) boost to the defense budget for 2025-26. The investment will be tabled in Parliament through supplementary estimates and directed toward rebuilding the Canadian Armed Forces, upgrading equipment, and expanding domestic production capabilities. The new defense posture includes reassessing major procurement decisions, such as the planned purchase of U.S.-made F-35 jets, and prioritizing partnerships with European firms for equipment acquisitions. Carney emphasized that three-quarters of Canada's defense capital spending has gone to the U.S., a pattern he said must end. "We're doing this for us," Carney was quoted as saying. "Relatedly we're doing it as a strong NATO partner, we're a firm believer in NATO, and we're standing shoulder to shoulder with our NATO allies, we'll continue to do so. ." Carney's announcement comes just ahead of the NATO leaders' summit in late June, where member states are expected to commit to higher defense spending thresholds of up to 5%. The prime minister said Canada would support a new NATO defense industrial pledge and participate in the EU's ReArm Europe initiative. He added that future cooperation with the EU will be a major theme of the upcoming Canada-EU summit. Read also: Ukraine war latest: Ukraine shoots down nearly 500 drones, missiles in Russian record strike, Air Force says We've been working hard to bring you independent, locally-sourced news from Ukraine. Consider supporting the Kyiv Independent.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store